Clinical Trial Opportunity for Triple-Negative Breast Cancer
| Date | Form | Description | XBRL | Pages |
|---|---|---|---|---|
| 06/09/26 | 3 | Form 3: Initial statement of beneficial ownership of securities | 2 | |
| 06/05/26 | SCHEDULE 13G | Form SCHEDULE 13G: Statement of Beneficial Ownership by Certain Investors | 6 | |
| 06/02/26 | EFFECT | Form EFFECT: Notice of Effectiveness | 1 | |
| 06/02/26 | 424B3 | Form 424B3: Prospectus [Rule 424(b)(3)] | 47 | |
| 05/29/26 | S-1/A | Form S-1/A: General form for registration of securities under the Securities Act of 1933 |
|
62 |
| 05/28/26 | DEFA14A | Form DEFA14A: Additional definitive proxy soliciting materials and Rule 14(a)(12) material | 3 | |
| 05/28/26 | DEF 14A | Form DEF 14A: Definitive proxy statements |
|
62 |
| 05/19/26 | S-1 | Form S-1: General form for registration of securities under the Securities Act of 1933 |
|
61 |
| 05/18/26 | PRE 14A | Form PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
51 |
| 05/18/26 | 8-K | Form 8-K: Current report |
|
3 |